发明授权
- 专利标题： Combination therapy of a type II anti-CD20 antibody with a selective BCL-2 inhibitor
-
申请号： US16827650申请日： 2020-03-23
-
公开(公告)号： US10993942B2公开(公告)日： 2021-05-04
- 发明人: Deepak Sampath , Christian Klein , Wayne John Fairbrother , Sari L. Heitner Enschede , Rod A. Humerickhouse , Andrew W. Roberts , John F. Seymour
- 申请人： GENENTECH, INC. , HOFFMANN-LA ROCHE INC. , ABBVIE INC.
- 申请人地址： US CA South San Francisco; US NJ Little Falls; US IL North Chicago
- 专利权人： GENENTECH, INC.,HOFFMANN-LA ROCHE INC.,ABBVIE INC.
- 当前专利权人： GENENTECH, INC.,HOFFMANN-LA ROCHE INC.,ABBVIE INC.
- 当前专利权人地址： US CA South San Francisco; US NJ Little Falls; US IL North Chicago
- 代理机构： Jones Day
- 主分类号： A61K31/496
- IPC分类号： A61K31/496 ; A61P35/02 ; A61P35/00
摘要：
The present invention is directed to a combination therapy involving a type II anti-CD20 antibody and a selective Bcl-2 inhibitor for the treatment of a patient suffering from cancer, particularly, a CD20-expressing cancer.
公开/授权文献
信息查询
IPC分类:
